Completed PHASE4 INTERVENTIONAL 2-arm NCT01212666

The Efficacy of Adductor-Canal-Block (ACB) in Patients After Anterior Cruciate Ligament (ACL) Reconstruction

The Effect of Adductor-Canal-Block (ACB) in Patients After Anterior Cruciate Ligament (ACL) Reconstruction in Day Case Surgery

Sponsor: Glostrup University Hospital, Copenhagen

Conditions Anterior Cruciate Ligament Reconstruction

Interventions Ropivacain Saline

Updated 5 times since 2017 Last updated: Sep 9, 2012 Started: May 31, 2010 Primary completion: Mar 31, 2012 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Anterior Cruciate Ligament Reconstruction and is currently completed. Glostrup University Hospital, Copenhagen leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Glostrup University Hospital, Copenhagen

Data source: Glostrup University Hospital, Copenhagen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark